Low patient accrual rates cause termination of over 25 per cent rare disease trials: GlobalData Read more
Launch of generic brands for expensive oncology drugs improves treatment affordability and access in India- GlobalData Read more
COVID-19 mRNA vaccines can face uptake issues over disinformation and safety concerns: GlobalData Read more